GSK turned the most up-to-date pharmaceutical team to lift its earnings advice to the year, since it described strong sales of its HIV and most cancers medications.Tomasz Wieladek, chief European economist at T Rowe Price, mentioned that inflation were pushed by mounting rates for items in lieu of solutions.Share $GSK lifts earnings forecast on bac